Michael O'Connell, Chief Analytics Officer at Spotfire, on his journey to technology leadership in energy management ...
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that results from an analysis of 160 real-world patients with ...
14don MSN
Dozens of blind people can see thanks to revolutionary new microchip: ‘Never been done before’
"Before receiving the implant, it was like having two black discs in my eyes, with the outside distorted," said Sheila Irvine ...
About Vaxxas Vaxxas is a biotechnology company pioneering a needle-free vaccination technology designed to enhance immune response, reduce costs, and improve accessibility. The company recently ...
China Medical University leads a multi-institution team reporting that MTAP deficiency suppresses cytosolic nucleic acid ...
AI translates electrical signals to the brain to help restore reading vision to treat a common form of blindness that was ...
Geographic atrophy, an advanced form of dry age-related macular degeneration, leaves almost five million people around the ...
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that Dr. Sean Lyden, Dr. Joseph Campbell, and Dr. Peter ...
Brisbane-based ObvioHealth has signed a three-year agreement with clinical-stage biotechnology company Vaxxas to support late-stage trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback